2. Wu AH. The ischemia-modified albumin biomarker for myocardial ischemia. MLO Med Lab Obs 2003. 35:36–40PMID : 12841070.
3. Jang EC, Jeon HK, Kim SH, Shin DI, Jeong HB, Shin JA, Shin WS, Jang KY, Kim YS, Lee HK, Choi KH, Youn HJ, Chung WS, Kim JH, Hong SJ, Seung KB. The usefulness of ischemia modified albumin as an early ischemic marker to detect coronary artery disease in patients with chest pain presenting to the emergency department. Korean J Med 2006. 71:620–626.
4. Kim KS, Shin SD, Song KJ, Suh GJ, Shin S. Prognosis of patients with out-of-hospital cardiac arrest and early biochemical markers: ischemia modified albumin, procalictonin, and S-100 protein. J Korean Soc Emerg Med 2006. 17:281–290.
5. Kim JY, Yoon J, Jung IH, Wang HS, Choi H, Jung HS, Kim H, Yoo BS, Lee SW, Uh Y, Hwang SO, Choe KH. A diagnostic value of ischemia modified albumin in patients with suspected acute coronary syndrome with normal EKG and cardiac markers. Korean Circ J 2005. 35:928–933.
6. Kang SY, Suh JT, Lee W. Clinical usefulness of ischemia modified albumin in acute coronary syndrome. Korean J Lab Med 2005. 25:306–311.
7. Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, Gaze D, Collinson P, Carlos Kaski J. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004. 97:297–301PMID : 15458698.
8. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003. 107:2403–2405PMID : 12742986.
9. Garrido IP, Roy D, Calvino R, Vazquez-Rodriguez JM, Aldama G, Cosin-Sales J, Quiles J, Gaze DC, Kaski JC. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am J Cardiol 2004. 93:88–90PMID : 14697474.
10. Quiles J, Roy D, Gaze D, Garrido IP, Avanzas P, Sinha M, Kaski JC. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 2003. 92:322–324PMID : 12888145.
11. Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 2002. 48:1097–1100PMID : 12089181.
12. Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, Kaski JC. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 2004. 50:1656–1660PMID : 15265817.
13. Sbarouni E, Georgiadou P, Theodorakis GN, Kremastinos DT. Ischemia-modified albumin in relaltion to exercise stress testing. J Am Coll Cardiol 2006. 48:2482–2484PMID : 17174185.
14. van der Zee PM, Verberne HJ, van Straalen JP, Sanders GT, van Eck-Smit BL, de Winter RJ, Fischer JC. Ischemia-modified albumin measurements in symptom-limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia. Clin Chem 2005. 51:1744–1746PMID : 16120959.
15. Mead WF. Maximal exercise testing: Bruce protocol. J Fam Pract 1979. 9:479–490PMID : 479779.
17. Zapico-Muñiz E, Santaló-Bel M, Mercé-Muntañola J, Montiel JA, Martínez-Rubio A, Ordóñez-Llanos J. Ischemia-modified albumin during skeletal muscle ischemia. Clin Chem 2004. 50:1063–1065PMID : 15161723.